Personal information

Germany

Activities

Employment (1)

Universitätsklinikum Tübingen: Tubingen, Baden-Württemberg, DE

Employment
Source: Self-asserted source
Juliane Haedicke-Jarboui

Works (13)

Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples

Cancer Medicine
2020-02 | Journal article
Contributors: Jasmin Fertey; Jörg Hagmann; Hans‐Joachim Ruscheweyh; Christian Munk; Susanne Kjaer; Daniel Huson; Juliane Haedicke‐Jarboui; Frank Stubenrauch; Thomas Iftner
Source: check_circle
Crossref

HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections.

American journal of cancer research
2018-04 | Journal article
Contributors: Manawapat-Klopfer A; Wang L; Haedicke-Jarboui J; Stubenrauch F; Munk C; Thomsen LT; Martus P; Kjaer SK; Iftner T
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions.

2016 | Journal article
Contributors: Manawapat-Klopfer A; Thomsen LT; Martus P; Munk C; Russ R; Gmuender H; Frederiksen K; Haedicke-Jarboui J; Stubenrauch F; Kjaer SK et al.
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

Involvement of Brd4 in different steps of the papillomavirus life cycle.

Virus research
2016-12 | Journal article
Contributors: Iftner T; Haedicke-Jarboui J; Wu SY; Chiang CM
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.

BMC infectious diseases
2016-11 | Journal article
Contributors: Iftner T; Wang L; Iftner A; Holz B; Haedicke-Jarboui J; Iftner N; von Wasielewski R; Martus P; Boehmer G
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.

2016-08 | Journal article
Contributors: Maple PA; Haedicke J; Quinlivan M; Steinberg SP; Gershon AA; Brown KE; Breuer J
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

A review of the clinical performance of the Aptima HPV assay.

2016-03 | Journal article
Contributors: Haedicke J; Iftner T
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.

2015-08 | Journal article
Contributors: Iftner T; Becker S; Neis KJ; Castanon A; Iftner A; Holz B; Staebler A; Henes M; Rall K; Haedicke J et al.
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo.

2014 | Journal article
Contributors: Leiprecht N; Notz E; Schuetz J; Haedicke J; Stubenrauch F; Iftner T
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off.

2014 | Journal article
Contributors: Boehmer G; Wang L; Iftner A; Holz B; Haedicke J; von Wasielewski R; Martus P; Iftner T
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

Human papillomaviruses and cancer.

2013-09 | Journal article
Contributors: Haedicke J; Iftner T
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

The brain-specific factor FEZ1 is a determinant of neuronal susceptibility to HIV-1 infection.

2009-08 | Journal article
Contributors: Haedicke J; Brown C; Naghavi MH
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central

The Ezrin-radixin-moesin family member ezrin regulates stable microtubule formation and retroviral infection.

2008-05 | Journal article
Contributors: Haedicke J; de Los Santos K; Goff SP; Naghavi MH
Source: Self-asserted source
Juliane Haedicke-Jarboui via Europe PubMed Central